September 29, 2022 | Posters & Presentations
Preclinical data demonstrating hydroxyl dendrimer (HD)-based PET tracer, [18F]OP-801 can be reproducibly synthesized and is suitable for human use.
September 29, 2022 | Posters & Presentations
Preclinical data demonstrating that our hydroxyl dendrimer (HD)-based PET tracer, [18F]OP-801, can detect activated macrophages and microglia with high sensitivity and specificity in an experimental autoimmune encephalomyelitis (EAE) murine model of multiple sclerosis (MS).
August 11, 2022 | Media
Clinical Trials Arena
July 31, 2022 | Posters & Presentations
Novel hydroxyl dendrimer-based PET tracer [18F]OP-801 detects early-stage neuroinflammation in 5xFAD mouse model with higher sensitivity than TSPO-PET
July 26, 2022 | Media
Clinical Trials Arena
July 20, 2022 | Publications
Science Translational Medicine
July 12, 2022 | Media
Empowered Patient Podcast
June 24, 2022 | Media
Pharma’s almanac
June 24, 2022 | Media
Pharma’s almanac
June 22, 2022 | Media
Pharmaceutical Technology